AFL vs. CNC, HUM, PFG, IBKR, TRV, MFG, COIN, TFC, O, and SPG
Should you be buying Aflac stock or one of its competitors? The main competitors of Aflac include Centene (CNC), Humana (HUM), Principal Financial Group (PFG), Interactive Brokers Group (IBKR), Travelers Companies (TRV), Mizuho Financial Group (MFG), Coinbase Global (COIN), Truist Financial (TFC), Realty Income (O), and Simon Property Group (SPG).
Centene (NYSE:CNC) and Aflac (NYSE:AFL) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, community ranking, valuation, earnings and institutional ownership.
Centene received 442 more outperform votes than Aflac when rated by MarketBeat users. Likewise, 73.25% of users gave Centene an outperform vote while only 57.39% of users gave Aflac an outperform vote.
Centene has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Comparatively, Aflac has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500.
In the previous week, Centene had 17 more articles in the media than Aflac. MarketBeat recorded 44 mentions for Centene and 27 mentions for Aflac. Centene's average media sentiment score of 0.95 beat Aflac's score of 0.61 indicating that Aflac is being referred to more favorably in the news media.
Aflac has lower revenue, but higher earnings than Centene. Aflac is trading at a lower price-to-earnings ratio than Centene, indicating that it is currently the more affordable of the two stocks.
Centene currently has a consensus target price of $85.23, indicating a potential upside of 14.31%. Aflac has a consensus target price of $82.31, indicating a potential upside of 0.07%. Given Aflac's stronger consensus rating and higher probable upside, equities analysts plainly believe Centene is more favorable than Aflac.
Aflac has a net margin of 27.67% compared to Aflac's net margin of 1.76%. Centene's return on equity of 17.24% beat Aflac's return on equity.
93.6% of Centene shares are held by institutional investors. Comparatively, 67.4% of Aflac shares are held by institutional investors. 0.3% of Centene shares are held by company insiders. Comparatively, 0.9% of Aflac shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Centene beats Aflac on 10 of the 18 factors compared between the two stocks.
Get Aflac News Delivered to You Automatically
Sign up to receive the latest news and ratings for AFL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
